Chinese DrugCo Prices IPO

Simcere Pharmaceutical Group, a Chinese generic drug-maker, priced 15.6 million American depository shares at $14.50 per share ($12.50-$14.50 range), for an IPO take of approximately $226.6 million. It plans to trade on the NYSE under ticker symbol SCR, with Goldman Sachs (Asia) serving as lead underwriter. Shareholders include Hony Capital.